年龄相关性黄斑变性：诊断、治疗及预防的新见解
Age-Related Macular Degeneration: New Insights in Diagnosis, Treatment, and Prevention.
作者信息
Mathis Thibaud, Kodjikian Laurent
机构信息
Service d'Ophtalmologie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, 69004 Lyon, France.
UMR CNRS 5510 MATEIS, Université Lyon 1, 69100 Villeurbanne, France.
出版信息
J Clin Med. 2022 Feb 18;11(4):1064. doi: 10.3390/jcm11041064.
Abstract
Age-related macular degeneration (AMD) is an aging-related ocular disease that can be responsible for severe loss of visual acuity and loss of autonomy in patients [...].
摘要
年龄相关性黄斑变性（AMD）是一种与衰老相关的眼部疾病，可导致患者严重视力丧失和生活不能自理[...]。
相似文献
1
Age-Related Macular Degeneration: New Insights in Diagnosis, Treatment, and Prevention.年龄相关性黄斑变性：诊断、治疗及预防的新见解
J Clin Med. 2022 Feb 18;11(4):1064. doi: 10.3390/jcm11041064.
2
Comparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular Health.年龄相关性黄斑变性最早阶段老年眼的视觉功能与正常黄斑健康者视觉功能的比较。
Curr Eye Res. 2016;41(2):266-72. doi: 10.3109/02713683.2015.1011282. Epub 2015 Mar 24.
3
Correlation of macular sensitivity measures and visual acuity to vision-related quality of life in patients with age-related macular degeneration.年龄相关性黄斑变性患者的黄斑敏感性测量值与视力相关生活质量的相关性。
BMC Ophthalmol. 2021 Mar 23;21(1):149. doi: 10.1186/s12886-021-01901-x.
4
Prevention and treatment of age-related macular degeneration: an update for pharmacists.年龄相关性黄斑变性的预防与治疗：药剂师须知的最新进展
Consult Pharm. 2013 Nov;28(11):723-37. doi: 10.4140/TCP.n.2013.723.
5
Age related macular degeneration and visual disability.年龄相关性黄斑变性与视力障碍。
Curr Drug Targets. 2011 Feb;12(2):221-33. doi: 10.2174/138945011794182755.
6
Local Abundance of Macular Xanthophyll Pigment Is Associated with Rod- and Cone-Mediated Vision in Aging and Age-Related Macular Degeneration.黄斑叶黄素色素的局部丰度与衰老和年龄相关性黄斑变性中的杆状和锥状介导视觉有关。
Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):46. doi: 10.1167/iovs.61.8.46.
7
Experiences with the Scharioth Macula Lens - new hope for patients with dry macular degeneration.沙里奥思黄斑镜片的使用经验——干性黄斑变性患者的新希望。
Rom J Ophthalmol. 2019 Apr-Jun;63(2):128-134.
8
Assessment of vision-related function in patients with age-related macular degeneration.年龄相关性黄斑变性患者视觉相关功能评估
Ophthalmology. 2002 Apr;109(4):720-9. doi: 10.1016/s0161-6420(01)01021-1.
9
Macular Function in Early and Intermediate Age-related Macular Degeneration: Correlation with the Simplified Thea Risk Assessment Scale (STARS).早、中年年龄相关性黄斑变性的黄斑功能：与简化的西娅风险评估量表（STARS）的相关性
Transl Vis Sci Technol. 2020 Sep 28;9(10):28. doi: 10.1167/tvst.9.10.28. eCollection 2020 Sep.
10
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.玻璃体内曲安奈德治疗年龄相关性黄斑变性的临床证据。
Curr Drug Targets. 2011 Feb;12(2):149-72. doi: 10.2174/138945011794182746.
引用本文的文献
1
Serum RNA Profile Reflects Fluid Status and Atrophic Retinal Changes in Neovascular Age-Related Macular Degeneration.血清RNA谱反映新生血管性年龄相关性黄斑变性的体液状态和视网膜萎缩性变化。
Int J Mol Sci. 2025 May 19;26(10):4852. doi: 10.3390/ijms26104852.
2
Mechanisms Underlying Vascular Inflammaging: Current Insights and Potential Treatment Approaches.血管炎症衰老的潜在机制：当前见解与潜在治疗方法
Aging Dis. 2024 Oct 18;16(4):1889-1917. doi: 10.14336/AD.2024.0922.
本文引用的文献
1
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression.临床实践中新生血管性年龄相关性黄斑变性的管理：系统评价、Meta分析和Meta回归
J Clin Med. 2022 Jan 10;11(2):325. doi: 10.3390/jcm11020325.
2
Exploring Consensus on Preventive Measures and Identification of Patients at Risk of Age-Related Macular Degeneration Using the Delphi Process.运用德尔菲法探讨年龄相关性黄斑变性预防措施及高危患者识别的共识
J Clin Med. 2021 Nov 20;10(22):5432. doi: 10.3390/jcm10225432.
3
Efficacy of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-Related Macular Degeneration and Systemic Cardiovascular Risk Factors.抗血管内皮生长因子治疗在新生血管性年龄相关性黄斑变性及全身心血管危险因素中的疗效
J Clin Med. 2021 Oct 6;10(19):4595. doi: 10.3390/jcm10194595.
4
EFFICACY AND SAFETY OF AFLIBERCEPT FOR THE TREATMENT OF IDIOPATHIC CHOROIDAL NEOVASCULARIZATION IN YOUNG PATIENTS: The INTUITION Study.阿柏西普治疗青年特发性脉络膜新生血管的疗效和安全性：INTUITION 研究。
Retina. 2022 Feb 1;42(2):290-297. doi: 10.1097/IAE.0000000000003310.
5
Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study.初始按需使用布罗珠单抗治疗渗出性年龄相关性黄斑变性：PROBE研究。
J Clin Med. 2021 Sep 15;10(18):4153. doi: 10.3390/jcm10184153.
6
Prevention of the Onset of Age-Related Macular Degeneration.预防年龄相关性黄斑变性的发病
J Clin Med. 2021 Jul 26;10(15):3297. doi: 10.3390/jcm10153297.
7
Meteorin Is a Novel Therapeutic Target for Wet Age-Related Macular Degeneration.Meteorin是湿性年龄相关性黄斑变性的新型治疗靶点。
J Clin Med. 2021 Jul 2;10(13):2973. doi: 10.3390/jcm10132973.
8
The Spectrum of Central Choriocapillaris Abnormalities on Swept-Source Optical Coherence Tomography Angiography in the Fellow Eye of Unilateral Exudative Age-Related Macular Degeneration Patients: From Flow Deficits to Subclinical Non-Exudative Neovascularization.单侧渗出性年龄相关性黄斑变性患者对侧眼扫频源光学相干断层扫描血管造影显示的中心脉络膜毛细血管异常谱：从血流缺失到亚临床非渗出性新生血管形成
J Clin Med. 2021 Jun 16;10(12):2658. doi: 10.3390/jcm10122658.
9
Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes.在对雷珠单抗或阿柏西普反应不完全的新生血管性年龄相关性黄斑变性中转换为布罗鲁单抗：真实世界6个月的结果
J Clin Med. 2021 Jun 17;10(12):2666. doi: 10.3390/jcm10122666.
10
Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study.布罗芦izumab治疗湿性年龄相关性黄斑变性的真实世界经验：REBA研究
J Clin Med. 2021 Jun 23;10(13):2758. doi: 10.3390/jcm10132758.
Zotero 插件